ISRCTN81868024已完成不适用
A randomised, double-blind, controlled study on the effect of one year administration of a nutritional concept on immunological status in human immunodeficiency virus-1 positive adults not on anti-retroviral therapy
umico Research B.V. (The Netherlands)0 个研究点目标入组 800 人开始时间: 2007年2月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Main inclusion criteria:
- •1. HIV-1 positive adults who have not received (Highly Active) Anti-Retroviral Therapy ([HA]ART) in the past year and are not anticipated to start therapy within the next six months
- •2. HIV-1 Ribonucleic Acid (RNA) more than 5,000 copies/ml in the three months prior to screening visit
- •3. CD4+ T-cell count less than or equal to 800 cells/µl in the three months prior to screening visit
- •4. More than or equal to 18 years old
排除标准
- •Main exclusion criteria:
- •1. (HA)ART anticipated to be required within the next six months
- •2. Unintended weight loss of more than 10% in the three months prior to screening visit
研究者
相似试验
招募中
1 期
A randomized, double-blind, controlled study on the treatment of stable vitiligo with compound Honghuabuji granulesITMCTR2100004855Shanghai Dermatology Hospital
进行中（未招募）
不适用
A randomised, controlled, double blind study of the immunogenicity and safety of Pediacel™, a combined diphtheria, tetanus, five component acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed) compared to Infanrix™–IPV+Hib when both vaccines are given to infants using a three dose immunisation schedule (Nordic schedule” 3-5-12 months)EUCTR2005-004133-17-FISanofi Pasteur Incorporated800
进行中（未招募）
不适用
A randomised, controlled, double blind study of the immunogenicity and safety of PEDIACEL®, a combined diphtheria, tetanus, five component acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed) compared to Infanrix™–IPV+Hib when both vaccines are given to infants using a three dose immunisation schedule (Nordic schedule” 3-5-12 months)PEDIACEL® is a fully liquid combination vaccine indicated for infants from 2 months of age to protect against diseases caused by 5 common pathogens: Haemophilus influenzae type b, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, and poliovirus types 1, 2 and 3.EUCTR2005-004133-17-SESanofi Pasteur Incorporated800
已完成
不适用
A randomized, double-blind and controlled study of clearing heat and resolving depression in the treatment of bipolar depression and fire heat depressioBipolar disorderITMCTR2200005825Beijing Anding Hospital, Capital Medical University
招募中
3 期
Study on the efficacy of Probiotics in the treatment of Asthma in children and adolescentsAsthmaRBR-7jsgnshHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo